Kaye Randall

Avg. Two Year Performance

18% Avg. Purchase Return
8% Compound
(39%) Avg. Sale Return
(18%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(14%)(3%)(13%)(8%)18%
Purchase Success Rate3 of 41 of 41 of 42 of 42 of 4
Average Sale Return(10%)(6%)(18%)(9%)(39%)
Sale Success Rate3 of 95 of 92 of 95 of 94 of 9
Drugs » Drug Manufacturers - Other

Sr. VP, Chief Medical Officer:

Holdings: 78.19K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Medical Officer:

Holdings: 6.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

CMO:

Holdings: 17.92K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--